ALPMY (ALPMY) Stock Price & Analysis
ALPMY (ALPMY) fell 1.41% to USD 13.3 as of June 9, 2026 at 23:52 UTC, according to Nexqual real-time market data.
ALPMY last closed at USD 13.49; the session ranged USD 13.3–13.44 on volume of 12,824 shares. Market capitalization is $23.83B, with a 52-week range of USD 9.11–17.35 (PNK). Source: Nexqual, June 9, 2026 at 23:52 UTC.
Key Statistics (as of June 9, 2026 at 23:52 UTC)
| Price | USD 13.3 |
|---|---|
| Change | ▼ 1.41% (down) |
| Previous Close | USD 13.49 |
| Open | USD 13.44 |
| Day Range | USD 13.3 – 13.44 |
| 52-Week Range | USD 9.11 – 17.35 |
| Volume | 12,824 shares |
| Market Cap | $23.83B |
| Exchange | PNK |
Technical Analysis (ALPMY)
Nexqual's technical model rates ALPMY "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 9, 2026 at 23:52 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.7 (neutral) |
| vs SMA50 | Below (USD 14.93) |
| MACD | -0.42 (negative) |
Analyst Ratings (ALPMY)
Wall Street analysts rate ALPMY "Strong Buy" based on 1 analysts, with a mean price target of USD 17.4 (range USD 17.4–17.4), per Nexqual as of June 9, 2026 at 23:52 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 17.4 |
| High Target | USD 17.4 |
| Low Target | USD 17.4 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (ALPMY)
| Next Earnings Date | 2026-04-27 |
|---|---|
| Revenue Estimate | $562.30B |
Source: Nexqual, June 9, 2026 at 23:52 UTC.
Financials & Fundamentals (ALPMY)
| Total Revenue | $2.14T |
|---|---|
| Revenue Growth (YoY) | +20.70% |
| Gross Margin | +80.91% |
| Operating Margin | +16.51% |
| Profit Margin | +13.63% |
| ROE | +17.44% |
| Debt / Equity | 30.91 |
| Current Ratio | 1.17 |
| Total Cash | $281.61B |
| Total Debt | $565.95B |
| Free Cash Flow | $388.72B |
Source: Nexqual, June 9, 2026 at 23:52 UTC.
Financial Health Score (ALPMY)
Nexqual rates ALPMY's overall financial health "Strong" across five dimensions, as of June 9, 2026 at 23:52 UTC.
| Growth | Strong — Revenue +171% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 81%, operating 17% |
| Balance Sheet | Solid — $281.6B cash vs $566.0B debt |
| Cash Flow | Strong — FCF $388.7B, 18% margin |
| Efficiency | Solid — ROE 17%, ROA 6.9% |
Ownership (ALPMY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.03% |
| Shares Outstanding | 1.79B |
| Float | 1.79B |
Source: Nexqual, June 9, 2026 at 23:52 UTC.
Leadership (ALPMY)
ALPMY is led by Naoki Okamura BSc (age 63), President, CEO & Director, per Nexqual as of June 9, 2026 at 23:52 UTC.
| President, CEO & Director | Naoki Okamura BSc (age 63) |
|---|---|
| Executive VP, Chief People Officer & Representative Director | Katsuyoshi Sugita (age 58) |
| Senior Executive Officer & CFO | Atsushi Kitamura |
| Chief Scientific Officer & Senior Managing Executive Officer | Yoshitsugu Shitaka |
| President of Japan Commercial & Senior Corporate Executive | Nobuaki Tanaka |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DSNKY | Daiichi Sankyo Co., Ltd. | USD 15.93 | ▲ 4.05% |
| ALPMF | Astellas Pharma, Inc. | USD 14.26 | ▲ 0.42% |
| OTSKY | Otsuka Holdings Co. Ltd. | USD 31.86 | ▼ 2.03% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
| SGIOY | Shionogi & Co. Ltd. | USD 8.56 | ▼ 2.28% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:52 UTC. This page is informational and not investment advice.